Compare UBC Medical Indonesia Tbk. (LABS) vs Multistrada Arah Sarana Tbk. (MASA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Multistrada Arah Sarana Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Multistrada Arah Sarana Tbk. trades at Rp6,200 (market cap 56.93T). The key difference: Multistrada Arah Sarana Tbk. is far larger — about 82.4× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LABS | MASA | |
|---|---|---|
Market Cap | 691.25B | 56.93T |
Volume | 635.5K | — |
Lot | 6.36K | — |
Turnover | 110.15M | — |
Average Price | 173.33 | — |
Value | 110.15M | — |
Indicative Equilibrium Price | 174 | — |
Indicative Equilibrium Volume | 50 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Multistrada Arah Sarana Tbk.
Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.
Read more on MASA →
